Company intelligence / Profile preview

TryptageniX

San Diego, California, United States

Ownership: Public · ATAI
Development stage: Other

Overview

TryptageniX focuses on developing sustainable biosynthetic methods to manufacture bioidentical psychoactive compounds and new chemical entities for mental health treatments.

Therapeutic areas: Psychiatry
Industry: Biotech

Partnerships

atai Life SciencesCB Therapeutics

Beyond the preview

Go deeper on TryptageniX.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TryptageniX.

Explore the full profile